Exercise Programs Show Promise in Mitigating Chemo Brain, Study Finds

Event summary

  • A phase III trial found that patients following the EXCAP exercise program during 2-week chemotherapy cycles reported less cognitive impairment and mental fatigue.
  • The study involved 687 patients across 20 community oncology practices in the U.S.
  • Patients in the EXCAP group maintained daily walking, while non-exercising patients reduced walking by 53%.
  • Benefits were less significant for patients on 3- to 4-week chemotherapy cycles.
  • The study was published in the March 2026 issue of JNCCN.

The big picture

The study highlights the potential of non-pharmacologic interventions like exercise to manage cognitive impairment during chemotherapy, aligning with broader trends in supportive cancer care. The findings reinforce recommendations in the NCCN Guidelines for Survivorship, emphasizing accessible and low-cost interventions to improve patient outcomes. This research could influence how oncology practices integrate exercise into treatment protocols, particularly for patients on shorter chemotherapy cycles.

What we're watching

Clinical Adoption
Whether cancer care providers will widely incorporate structured exercise programs into routine chemotherapy care.
Patient Engagement
The extent to which patients adhere to exercise prescriptions during chemotherapy.
Future Research
The pace at which additional studies expand on the patient population to generalize these findings.

Related topics

Oncology